Shares of Hoya Corp. (OTCMKTS:HOCPY - Get Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $131.31 and traded as high as $144.99. Hoya shares last traded at $144.78, with a volume of 55,923 shares trading hands.
Analysts Set New Price Targets
Several brokerages recently commented on HOCPY. The Goldman Sachs Group raised Hoya from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, July 23rd. Nomura Securities raised shares of Hoya to a "strong-buy" rating in a report on Monday, August 18th. Three analysts have rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Strong Buy".
Check Out Our Latest Research Report on HOCPY
Hoya Trading Down 3.6%
The business's 50-day moving average price is $131.68 and its two-hundred day moving average price is $121.75. The company has a market capitalization of $47.89 billion, a P/E ratio of 34.89, a PEG ratio of 2.98 and a beta of 0.94. The company has a debt-to-equity ratio of 0.03, a current ratio of 5.19 and a quick ratio of 4.46.
Hoya (OTCMKTS:HOCPY - Get Free Report) last announced its quarterly earnings results on Friday, August 1st. The technology company reported $1.05 earnings per share for the quarter, beating analysts' consensus estimates of $1.04 by $0.01. Hoya had a net margin of 23.57% and a return on equity of 21.01%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.47 billion. As a group, analysts forecast that Hoya Corp. will post 3.66 EPS for the current fiscal year.
Hoya Company Profile
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Further Reading
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.